Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21.

Macrophage polarization between the M2 (repair, protumorigenic) and M1 (inflammatory) phenotypes is seen as a continuum of states. The detailed transcriptional events and signals downstream of colony-stimulating factor 1 receptor (CSF-1R) that contributes to amplification of the M2 phenotype and suppression of the M1 phenotype are largely unknown. Macrophage CSF-1R pTyr-721 signaling promotes cell motility and enhancement of tumor cell invasion in vitro. Combining analysis of cellular systems for CSF-1R gain of function and loss of function with bioinformatic analysis of the macrophage CSF-1R pTyr-721-regulated transcriptome, we uncovered microRNA-21 (miR-21) as a downstream molecular switch controlling macrophage activation and identified extracellular signal-regulated kinase1/2 and nuclear factor-κB as CSF-1R pTyr-721-regulated signaling nodes. We show that CSF-1R pTyr-721 signaling suppresses the inflammatory phenotype, predominantly by induction of miR-21. Profiling of the miR-21-regulated messenger RNAs revealed that 80% of the CSF-1-regulated canonical miR-21 targets are proinflammatory molecules. Additionally, miR-21 positively regulates M2 marker expression. Moreover, miR-21 feeds back to positively regulate its own expression and to limit CSF-1R-mediated activation of extracellular signal-regulated kinase1/2 and nuclear factor-κB. Consistent with an anti-inflammatory role of miRNA-21, intraperitoneal injection of mice with a miRNA-21 inhibitor increases the recruitment of inflammatory monocytes and enhances the peritoneal monocyte/macrophage response to lipopolysaccharide. These results identify the CSF-1R-regulated miR-21 network that modulates macrophage polarization.

[1]  H. Jo,et al.  Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs. , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Michael C. Ostrowski,et al.  CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth , 2014, Oncogene.

[3]  S. Goerdt,et al.  Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.

[4]  E. Stanley,et al.  CSF-1 receptor signaling in myeloid cells. , 2014, Cold Spring Harbor perspectives in biology.

[5]  J. Noto,et al.  Matrix metalloproteinase 7 restrains Helicobacter pylori-induced gastric inflammation and premalignant lesions in the stomach by altering macrophage polarization , 2014, Oncogene.

[6]  M. Fu,et al.  MicroRNA-155 Deficiency Results in Decreased Macrophage Inflammation and Attenuated Atherogenesis in Apolipoprotein E–Deficient Mice , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Y. H. Chen,et al.  MicroRNA-21 regulates T-cell apoptosis by directly targeting the tumor suppressor gene Tipe2 , 2014, Cell Death and Disease.

[8]  V. Noé,et al.  Validation of miRNA-mRNA interactions by electrophoretic mobility shift assays , 2013, BMC Research Notes.

[9]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.

[10]  F. Pixley,et al.  Specific inhibition of PI3K p110δ inhibits CSF‐1‐induced macrophage spreading and invasive capacity , 2013, The FEBS journal.

[11]  I. Palmero,et al.  microRNA biogenesis and senescence , 2013, Aging.

[12]  Y. Akao,et al.  DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells. , 2013, Biochimica et biophysica acta.

[13]  M. Pittet,et al.  Therapeutically reeducating macrophages to treat GBM , 2013, Nature Medicine.

[14]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[15]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[16]  Yong‐jun Liu,et al.  The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. , 2013, Immunity.

[17]  Anushya Muruganujan,et al.  Large-scale gene function analysis with the PANTHER classification system , 2013, Nature Protocols.

[18]  M. Pittet,et al.  MicroRNA-mediated control of macrophages and its implications for cancer. , 2013, Trends in immunology.

[19]  S. Lemieux,et al.  Transcriptome sequencing of neonatal thymic epithelial cells , 2013, Scientific Reports.

[20]  S. Gordon,et al.  Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. , 2013, Blood.

[21]  E. Abraham,et al.  MicroRNAs in immune response and macrophage polarization. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[22]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[23]  Junfeng Zhang,et al.  Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155. , 2012, Journal of molecular cell biology.

[24]  Roberta Galli,et al.  MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response , 2012, Proceedings of the National Academy of Sciences.

[25]  Alberto Mantovani,et al.  Orchestration of metabolism by macrophages. , 2012, Cell metabolism.

[26]  J. Hamilton,et al.  Control of macrophage lineage populations by CSF‐1 receptor and GM‐CSF in homeostasis and inflammation , 2012, Immunology and cell biology.

[27]  A. Pasquinelli MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship , 2012, Nature Reviews Genetics.

[28]  Alberto Mantovani,et al.  Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.

[29]  F. Pixley,et al.  Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807* , 2012, The Journal of Biological Chemistry.

[30]  Guogen Mao,et al.  Modulation of microRNA processing by mismatch repair protein MutLα , 2012, Cell Research.

[31]  M. Bitzer,et al.  miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling. , 2011, Blood.

[32]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[33]  A. Chawla,et al.  Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.

[34]  M. Ingersoll,et al.  Monocyte trafficking in acute and chronic inflammation. , 2011, Trends in immunology.

[35]  R. Geffers,et al.  Macrophages at the Fetal–Maternal Interface Express Markers of Alternative Activation and Are Induced by M-CSF and IL-10 , 2011, The Journal of Immunology.

[36]  F. Su,et al.  Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells , 2011, Molecular Cancer.

[37]  S. Orkin,et al.  MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN-γ Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity , 2011, The Journal of Immunology.

[38]  Wei Xu,et al.  Macrophage Differentiation and Polarization via Phosphatidylinositol 3-Kinase/Akt–ERK Signaling Pathway Conferred by Serum Amyloid P Component , 2011, The Journal of Immunology.

[39]  J. Condeelis,et al.  Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion , 2011, Journal of Cell Science.

[40]  F. Martínez Regulators of macrophage activation , 2011, European journal of immunology.

[41]  R. Flavell,et al.  Alternative activation of macrophages by IL‐4 requires SHIP degradation , 2011, European journal of immunology.

[42]  L. Boscá,et al.  Cot/tpl2 activity is required for TLR‐induced activation of the Akt p70 S6k pathway in macrophages: Implications for NO synthase 2 expression , 2011, European journal of immunology.

[43]  A. Puig-Kröger,et al.  Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. , 2011, Blood.

[44]  Yosef Yarden,et al.  Feedback regulation of EGFR signalling: decision making by early and delayed loops , 2011, Nature Reviews Molecular Cell Biology.

[45]  E. Stanley,et al.  Measurement of Macrophage Growth and Differentiation , 2011, Current protocols in immunology.

[46]  E. Stanley,et al.  A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation* , 2010, The Journal of Biological Chemistry.

[47]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[48]  Lisa C. Zaba,et al.  A subpopulation of CD163-positive macrophages is classically activated in psoriasis. , 2010, The Journal of investigative dermatology.

[49]  L. Williams,et al.  Functional overlap but differential expression of CSF‐1 and IL‐34 in their CSF‐1 receptor‐mediated regulation of myeloid cells , 2010, Journal of leukocyte biology.

[50]  Kevin Struhl,et al.  STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. , 2010, Molecular cell.

[51]  C. Ruhrberg,et al.  A double agent in cancer: Deciphering macrophage roles in human tumors , 2010, Nature Medicine.

[52]  D. Viemann,et al.  Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. , 2010, Blood.

[53]  Eran Segal,et al.  EGF Decreases the Abundance of MicroRNAs That Restrain Oncogenic Transcription Factors , 2010, Science Signaling.

[54]  S. Gordon,et al.  Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.

[55]  Loyal A Goff,et al.  Differential regulation of microRNA stability. , 2010, RNA.

[56]  E. Pålsson-McDermott,et al.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 , 2010, Nature Immunology.

[57]  Leonore A. Herzenberg,et al.  Two physically, functionally, and developmentally distinct peritoneal macrophage subsets , 2010, Proceedings of the National Academy of Sciences.

[58]  T. Lawrence The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[59]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[60]  C. Arce,et al.  Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis , 2009, BMC proceedings.

[61]  Marc E. Rothenberg,et al.  MicroRNA-21 Is Up-Regulated in Allergic Airway Inflammation and Regulates IL-12p35 Expression 1 , 2009, The Journal of Immunology.

[62]  T. Lawrence,et al.  Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB. , 2009, Blood.

[63]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[64]  K. Patterson,et al.  Dual-specificity phosphatases: critical regulators with diverse cellular targets. , 2009, The Biochemical journal.

[65]  Jasmyn A. Dunn,et al.  HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA , 2009, Science.

[66]  Jianjun Chen,et al.  miR-21 plays a pivotal role in gastric cancer pathogenesis and progression , 2008, Laboratory Investigation.

[67]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[68]  T. Weichhart,et al.  The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications , 2008, Annals of the rheumatic diseases.

[69]  Konstantinos N. Malizos,et al.  Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.

[70]  S. Brant,et al.  MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. , 2008, Gastroenterology.

[71]  Xia Zhang,et al.  The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.

[72]  Jing Chen,et al.  CSF‐1 receptor structure/function in MacCsf1r–/– macrophages: regulation of proliferation, differentiation, and morphology , 2008, Journal of leukocyte biology.

[73]  S. Rosenberg,et al.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.

[74]  J. Steitz,et al.  Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.

[75]  A. Lund,et al.  Isolation of microRNA targets using biotinylated synthetic microRNAs. , 2007, Methods.

[76]  S. Kasif,et al.  Immediate-Early and Delayed Primary Response Genes Are Distinct in Function and Genomic Architecture* , 2007, Journal of Biological Chemistry.

[77]  M. Lindsay,et al.  Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids , 2007, BMC Genomics.

[78]  L. Lim,et al.  MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.

[79]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[80]  Eytan Domany,et al.  A module of negative feedback regulators defines growth factor signaling , 2007, Nature Genetics.

[81]  Chunxiang Zhang,et al.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? , 2007, The American journal of pathology.

[82]  V. Kim,et al.  Processing of intronic microRNAs , 2007, The EMBO journal.

[83]  David Baltimore,et al.  MicroRNA-155 is induced during the macrophage inflammatory response , 2007, Proceedings of the National Academy of Sciences.

[84]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[85]  M. Caligiuri,et al.  FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. , 2006, Blood.

[86]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[87]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[88]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[89]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[90]  K. Schroder,et al.  Interferon‐γ: an overview of signals, mechanisms and functions , 2004 .

[91]  E. Stanley,et al.  Proteomic Approaches to the Analysis of Early Events in Colony-stimulating Factor-1 Signal Transduction* , 2003, Molecular & Cellular Proteomics.

[92]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[93]  Ivan Dikic,et al.  Negative receptor signalling. , 2003, Current opinion in cell biology.

[94]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[95]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[96]  J. Pow-Sang,et al.  Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma. , 2002, The Journal of urology.

[97]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[98]  M. Colonna,et al.  Cutting Edge: Signal-Regulatory Protein β1 Is a DAP12-Associated Activating Receptor Expressed in Myeloid Cells1 , 2000, The Journal of Immunology.

[99]  J. Johnston,et al.  B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. , 1994, Cancer research.

[100]  S Gordon,et al.  Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.

[101]  T. Pawson,et al.  Tyr721 regulates specific binding of the CSF‐1 receptor kinase insert to PI 3′‐kinase SH2 domains: a model for SH2‐mediated receptor‐target interactions. , 1992, The EMBO journal.

[102]  A. Orlofsky,et al.  CSF‐1‐induced gene expression in macrophages: dissociation from the mitogenic response. , 1987, The EMBO journal.

[103]  P. Kenny,et al.  miR-21 mediates hematopoietic suppression in MDS by activating TGF-b signaling , 2013 .

[104]  L. Dang,et al.  Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells. , 2006, Oncogene.

[105]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[106]  S. Gordon Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[107]  D. Hume,et al.  CSF-1 as a regulator of macrophage activation and immune responses. , 2003, Archivum immunologiae et therapiae experimentalis.

[108]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[109]  P Roth,et al.  The biology of CSF-1 and its receptor. , 1992, Current topics in microbiology and immunology.

[110]  E. Coligan Current protocols in immunology , 1991 .

[111]  R. Schwartz T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. , 1985, Annual review of immunology.